Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOKYN and Physical Therapy in Parkinson's Disease
NCT02549573Phase 4Terminated
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Jan 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apomorphine in Parkinson's disease (PD), sponsored by Supernus Pharmaceuticals, Inc.. Started Jan 2016; status: terminated.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02549573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549573.